SCHEMBL16256331

SCHEMBL16256331

CSN1C(=O)C=CC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL83079 0.73 MGLL (0.42)
SCHEMBL709406 0.73 MGLL (0.42)
SCHEMBL19848642 0.69 MGLL (0.39)
SCHEMBL19057261 0.69 MGLL (0.46)
SCHEMBL24003668 0.69
SCHEMBL4340966 0.69
SCHEMBL5577325 0.67 MGLL (0.43)
SCHEMBL20621537 0.63 MGLL (0.52)
SCHEMBL11749637 0.63 ALDH1A1 (0.47)
SCHEMBL2267922 0.63 GSK3A (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111978235-A Preparation method of 3-amino-4-methylmercaptomaleimide compound 温州医科大学 2020-11-24 CN claimed
WO-2024129628-A1 AURISTATIN LINKER-PAYLOADS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF MERCK SHARP & DOHME LLC (US) 2024-06-20 WO disclosed
US-20220332687-A1 HETEROARYL COMPOUNDS AND USES THEREOF SANOFI (FR) 2022-10-20 US disclosed
US-11384104-B2 Delivery systems for controlled drug release CENTURION BIOPHARMA CORPORATION (US) 2022-07-12 US disclosed
US-20210353765-A1 COMPOUNDS AND THERAPEUTIC USES THEREOF AVVINITY THERAPEUTICS LIMITED (GB/GB) (GB) 2021-11-18 US disclosed
EP-3889154-A1 HETEROCYCLIC COMPOUND INTERMEDIATE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Wuhan LL Science And Technology Development Co., Ltd. (CN) 2021-10-06 EP disclosed
WO-2021195183-A1 COMPOSITIONS AND METHODS FOR INHIBITING PROTEIN EMBRYONIC ECTODERM DEVELOPMENT ACTIVITY AND TREATING DISEASE EXO THERAPEUTICS, INC. (US) 2021-09-30 WO disclosed
WO-2020236841-A2 ANTIBODY DRUG CONJUGATES HAVING LINKERS COMPRISING HYDROPHILIC GROUPS NOVARTIS AG (CH) 2020-11-26 WO disclosed
CN-111978235-A Preparation method of 3-amino-4-methylmercaptomaleimide compound 温州医科大学 2020-11-24 CN disclosed
CN-111978235-A Preparation method of 3-amino-4-methylmercaptomaleimide compound 温州医科大学 2020-11-24 CN disclosed
US-20180059541-A1 CLICK-CHEMISTRY COMPATIBLE STRUCTURES, CLICK-CHEMISTRY FUNCTIONALIZED STRUCTURES, AND MATERIALS AND METHODS FOR MAKING THE SAME U.S. DEPARTMENT OF ENERGY 2018-03-01 US disclosed
US-20180051031-A1 SECO-CYCLOPROPAPYRROLOINDOLE COMPOUNDS, ANTIBODY-DRUG CONJUGATES THEREOF, AND METHODS OF MAKING AND USE THE SCRIPPS RESEARCH INSTITUTE 2018-02-22 US disclosed
US-20180022713-A1 HETEROARYL COMPOUNDS AND USES THEREOF BRISTOL-MYERS SQUIBB COMPANY 2018-01-25 US disclosed
US-9717668-B2 Methods for treating relaxed hair LIQWD, INC. (US) 2017-08-01 US disclosed
US-9695132-B2 Heteroaryl compounds and uses thereof CELGENE CAR LLC (BM) 2017-07-04 US disclosed
US-9676785-B2 HCV protease inhibitors and uses thereof CELGENE CAR LLC (BM) 2017-06-13 US disclosed
US-9493394-B2 Photoaligning materials ROLIC AG (CH) 2016-11-15 US disclosed
US-9334366-B2 Photoaligning materials ROLIC AG (CH) 2016-05-10 US disclosed
US-20160062020-A1 RETARDATION FILM, AND CIRCULARLY POLARIZING PLATE AND IMAGE DISPLAY DEVICE USING THE RETARDATION FILM Konica Minolta, Inc. (JP) 2016-03-03 US disclosed
US-20140342086-A1 PHOTOALIGNING MATERIALS ROLIC AG (CH) 2014-11-20 US disclosed